EUVIMED · CrossrefZeitschrift
Cephalalgia
ISSN 0333-1024 · SAGE Publications
Neueste Artikel
Small molecules, big hopes: Gepants in cluster headache
Atogepant for preventive treatment of episodic cluster headache: A single-center case series of 18 patients
Short-term gepant use during active cluster headache bouts: A consecutive case series
Three-year safety, tolerability, clinical efficacy, and functional outcomes of atogepant for the preventive treatment of migraine: Final results from a phase 3, open-label extension study
Uludüz D et al. Migraine and headache in children and adolescents: A 2026 evidence-based factsheet
Authors’ reply to Steiner et al.: “Migraine and headache in children and adolescents: a 2026 evidence-based factsheet”
Migraine beyond attacks: Insights on the interictal phase
Restlessness in cluster headache: Rethinking a classic feature through behaviorally-anchored assessment
Beyond pacing: What does restlessness really mean in cluster headache?
Migraine is chronic – its frequency varies: Time to reconsider ‘episodic’ and ‘chronic’ migraine terminology
Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study
Association between migraine and angiogenic biomarkers in women with suspected or confirmed hypertensive disorders of pregnancy
Migraine and headache in children and adolescents: A 2026 evidence-based factsheet
Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC 1 /VPAC receptors
Treatment patterns and Reasons for Discontinuing Preventive Treatment in Cluster Headache: A prospective cohort study
Treatment outcomes in new daily persistent headache in children and adolescents
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Sex-specific orchestration of morphometric similarity networks in children and adolescents with migraine
Efficacy and effectiveness of anti-CGRP monoclonal antibodies treatment in the prevention of cluster headache attacks: A systematic review and meta-analysis
Influence of online health information and artificial intelligence on decision-making among migraine patients: A multinational cross-sectional study from the MENA region
Proposed changes to current definitions of ICHD-3 regarding headache and facial pain attributed to the disorder of the nose or paranasal sinuses
Efficacy and outcomes of pharmacological treatments for headaches after traumatic brain injury: A systematic review
Comparative diagnostic agreement of a supervised machine learning model and a general-purpose, zero-shot, non-domain-adapted large language model for classifying headache disorders using structured questionnaires
Toward quantifying disability in spontaneous intracranial hypotension: A patient-derived disability weight
Hypersensitivity to phosphodiesterase-5 inhibition in post-traumatic headache: Evidence of cGMP-dependent signaling
WHO's essential medicines list: Additions for migraine and cluster headache
Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS)
Post-traumatic headache two to four months after mild traumatic brain injury: A description of phenotypes and treatment patterns
Where are the men? A systematic review of sex bias in human provocation models of migraine
Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study
Jahrgänge
2026 · 1082025 · 1942024 · 1352023 · 1582022 · 1712021 · 1502020 · 1862019 · 1952018 · 2252017 · 1852016 · 1722015 · 1802014 · 1652013 · 1622012 · 1872011 · 2332010 · 2382009 · 2162008 · 2412007 · 2472006 · 2492005 · 1862004 · 2042003 · 1752002 · 1492001 · 2392000 · 2241999 · 2271998 · 2401997 · 1781996 · 1421995 · 2961994 · 1351993 · 1641992 · 1091991 · 2501990 · 531989 · 3021988 · 741987 · 283
EUVIMED